Study Stopped
Unable to enroll any participants.
Biodex Sit2Stand for Individuals With Cardiac Disease
The Effects of the Biodex Sit2Stand Trainer on Function for Individuals With Cardiac Disease
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Patients with cardiac disease have been shown to have deficits in activities such as standing up from a chair. The Biodex Sit2Stand Trainer is a new device meant to improve sit to stand performance by providing a lifting force through the seat to help the individual stand. The amount of lift can be graded to help improve leg strength, endurance, and function over time. The device has the potential to be a form of training for those in cardiac rehabilitation who have limitations in standing from a chair.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2017
Shorter than P25 for not_applicable coronary-artery-disease
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2017
CompletedFirst Posted
Study publicly available on registry
May 30, 2017
CompletedStudy Start
First participant enrolled
June 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2017
CompletedSeptember 19, 2019
September 1, 2019
4 months
May 14, 2017
September 17, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Short Physical Performance Battery
Lower extremity functional assessment tool which include gait speed, sit to stand ability and static balance
Week 0 and Week 7
Secondary Outcomes (5)
Change in Isometric knee extension strength
Week 0 and Week 7
Change in 10 meter gait speed
Week 0 and Week 7
Change in Six Minute Walk Test
Week 0 and Week 7
Change in HeartQoL
Week 0 and Week 7
Change in MacNew
Week 0 and Week 7
Study Arms (1)
Intervention
EXPERIMENTALThe training protocol will be include 12 sessions completed over six weeks following a periodization training format. Each session will last approximately 40 minutes. At first, training will focus on high volume, low intensity, self-selected velocity with a progression to high intensity, low volume, self-selected velocity ending with a focus on power training (moderate intensity, moderate volume, high velocity movement) over the six weeks of training.
Interventions
Week 1-2 - Focused on lower intensity, higher volume, comfortable/self-selected velocity Week 3-4 - Focus on higher intensity, lower volume, comfortable/self-selected velocity Week 5 - Focus on moderate intensity, moderate volume, transitioning to higher velocity Week 6 - Focus on moderate intensity, moderate volume, high velocity
Eligibility Criteria
You may qualify if:
- Completion of a cardiac rehabilitation
- Ability to walk 50 feet independently with or without an assistive device
- Inability to stand from a standard chair five times without the use of their arms or unable to complete five sit to stands in less than 15 seconds.
- No major cardiac arrhythmias during cardiac rehabilitation sessions.
- Ability to attend 14 sessions over a 7-8 week period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (6)
Jensen KH, Baekgaard N, Gaardsting O, Jelnes R, Tonnesen KH. [The social consequences of intermittent claudication]. Ugeskr Laeger. 1986 Oct 13;148(42):2715-7. No abstract available. Danish.
PMID: 3787784RESULTStevenson TG, Riggin K, Nagelkirk PR, Hargens TA, Strath SJ, Kaminsky LA. Physical activity habits of cardiac patients participating in an early outpatient rehabilitation program. J Cardiopulm Rehabil Prev. 2009 Sep-Oct;29(5):299-303. doi: 10.1097/HCR.0b013e3181b4ca61.
PMID: 19935142RESULTZullo MD, Dolansky MA, Jackson LW. Cardiac rehabilitation, health behaviors, and body mass index post-myocardial infarction. J Cardiopulm Rehabil Prev. 2010 Jan-Feb;30(1):28-34. doi: 10.1097/HCR.0b013e3181c8594b.
PMID: 20068420RESULTGoel K, Shen J, Wolter AD, Beck KM, Leth SE, Thomas RJ, Squires RW, Perez-Terzic CM. Prevalence of musculoskeletal and balance disorders in patients enrolled in phase II cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2010 Jul-Aug;30(4):235-9. doi: 10.1097/HCR.0b013e3181e17387.
PMID: 20551829RESULTAdes PA, Maloney A, Savage P, Carhart RL Jr. Determinants of physical functioning in coronary patients: response to cardiac rehabilitation. Arch Intern Med. 1999 Oct 25;159(19):2357-60. doi: 10.1001/archinte.159.19.2357.
PMID: 10547176RESULTPuthoff ML, Youngs B. Cardiac Rehabilitation Leads to Improvements in Activity Limitations. J Cardiopulm Rehabil Prev. 2017 Nov;37(6):424-427. doi: 10.1097/HCR.0000000000000220.
PMID: 28033164RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 14, 2017
First Posted
May 30, 2017
Study Start
June 1, 2017
Primary Completion
September 15, 2017
Study Completion
September 15, 2017
Last Updated
September 19, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share